Consuming more plant-based foods following prostate cancer diagnosis was associated with improved sexual function, among other QOL domains.

Clinical node involvement on preoperative PSMA-PET predicts radiographic recurrence for pN1 prostate cancer patients following RP/PLND.

Reduced-dose ARSI therapy in non-metastatic castration-resistant prostate cancer has similar efficacy and safety as the full dose.

Investigators evaluated the long-term neurological, neurocognitive, social, and quality of life outcomes associated with posterior fossa syndrome among survivors of medulloblastoma.

For patients with mCRPC with bone metastases, the addition of radium-223 to enzalutamide therapy is associated with improved overall survival.

In this population-based analysis, researchers aimed to assess whether menopausal hormone therapy increases the risk of all-cause mortality.

On Monday, the CDC announced that Ralph Abraham, its deputy secretary general, stepped down effective immediately. Abraham had been in the role for about two and a half months. In a statement posted ...

The presentations at ASCO GU signal a move toward more personalized, potent, and sequence-specific treatment strategies for genitourinary malignancies.

Patients in states that expanded Medicare were more likely to receive all guideline-concordant treatment, from 64.7% to 69.28% in expansion states versus 61.43% to 66.67% in states that did not expand ...

In this retrospective analysis, researchers studied adult patients who were diagnosed with non-metastatic breast cancer and received GLP1-RAs for at least 3 months.

FDA Commissioner Dr Marty Makary and his top deputy, Dr Vinay Prasad, detailed the plan Feb. 18 in The New England Journal of Medicine. The move is the latest in a series of FDA efforts to eliminate ...

Researchers determined AYAs with ALL trying to schedule oncology appointments face logistical burdens when accessing initial oncology care.